Author(s)
Mr. Jaydip Avinash Pawar, Mr. Pruthviraj Sunil Patil, Ms. Apurva Ravindra Pol, Ms. Srushti Gajendra. Sawant, Ms. Dipti Vijay Shendage , Ms. Swapnali Sanjay Patil, Dr. Rajesh Shankar Jagtap
- Manuscript ID: 140070
- Volume: 2
- Issue: 5
- Pages: 1–21
Subject Area: Robotics and Automation
Abstract
The pharmaceutical sector is quickly evolving using robotics, automation, and, more imminently, artificial intelligence that provide more recent approaches to long-standing issues of lengthy and expensive drug development and human error. Robotics are now firmly established as indispensable within the pharmaceutical value chain, embedded throughout all aspects, including drug discovery, manufacturing, packaging, logistics, and personalized medicine. Industrial robots provide a sterility, accuracy, and ability to produce continuously in high-volume production areas, while collaborative robots enable tasks deemed repetitive and laborious to allow researchers to move from tedious repetitive work. Automated dispensing and logistics operations can optimize the supply chain in terms of accuracy, safety, and efficiency; especially during high demand periods. AI-based vision and warehousing methods can undoubtedly improve quality assurance, traceable methods, and assurance of regulatory compliance. The newest approaches in technology, including nanorobotics and robotic 3D printing, are now starting to establish a base for individualized therapies for patients. Although the benefits of robotics are significant and clear, including reliability, less contamination risks, and lower costs over time to the consumer, there are still challenges including high start-up costs, disrupt existing workplace practices, displace labour, and heightened risk of cyber security issues. Nonetheless, the future has promise for robotics in the pharmaceutical industry.